HUMANIZED ANTIBODIES AGAINST PSMA

CY1125792T1Undetermined Publication Date: 2026-04-17HEIDELBERG PHARMA RES GMBH

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: CY20231100046T
Authority / Receiving Office: CY · CY
Patent Type: Patents
Current Assignee / Owner
Priority Date: 2018-07-31
Filing Date: 2023-01-27
Publication Date: 2026-04-17
Estimated Expiration: 2043-01-27

Application Information

Patent Timeline

31 Jul 2018

Priority

27 Jan 2023

Application

CY20231100046T

17 Apr 2026

Publication

CY1125792T1

IPC: C07K16/30; A61K39/00; C07K16/40

CPC: C07K16/3069; C07K16/40; C07K2317/24; C07K2317/56; C07K2317/565; C07K2317/622; A61K2039/505; A61P35/00

Inventors: HECHLER Torsten; PAHL Andreas

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

AI Tagging

Technology Topics

AntigenProstate specific membrane

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present application relates to humanized and / or deimmunized antibodies, antibody fragments or antibody derivatives that bind to Prostate Specific Membrane Antigen (PSMA), and to methods for using said antibodies, antibody fragments or antibody derivatives in the treatment of prostate cancer and other neoplastic as well as neurological diseases.

Need to check novelty before this filing date? Find Prior Art